Search filters

List of works by Giuseppe Badalamenti

Abstract LB-295: Detection of oncogenic kinase mutations in circulating plasma DNA and correlation with clinical benefit in the phase III GRID study of regorafenibvsplacebo in TKI-refractory metastatic GIST

article

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

scientific article

Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment options

scientific article published on 17 April 2013

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

scientific article

Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

scientific article

Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis

scientific article published on 24 September 2015

Lack of Correlation Between Liver Tests Abnormalities and Trabectedin Efficacy in the Treatment of Soft Tissue Sarcoma: a Retrospective Study

scientific article published on 3 August 2015

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.

scientific article

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey

scientific article

PML down-regulation in soft tissue sarcomas

scientific article published in September 2010

PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy

scientific article published on 01 April 2012